|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 17.70 EUR | -1.12% |
|
-3.76% | +14.01% |
| 01:14am | Sandoz results shine in 'golden decade' for biosimilars | RE |
| 08-03 | Correction to Novartis Wins FDA Approval for Expanded Prostate Cancer Treatment Article on July 31 | DJ |
Chart: Technical Analysis
MarketScreener's Technical Analysis Ratings
| Short Term Timing | |
|---|---|
| Middle Term Timing | |
| Long Term Timing | |
| RSI | |
| Bollinger Spread | |
| Unusual Volumes |
- Stock Market
- Stocks
- NOVN Stock
- NOT0 Stock
- Charts Novartis AG
Select your edition
All financial news and data tailored to specific country editions
